BioAge Labs, Inc. (BIOA)
5.355
-0.06
(-1.20%)
USD |
NASDAQ |
Oct 15, 13:57
BioAge Labs Total Long Term Debt (Quarterly) : 2.121M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.121M |
| March 31, 2026 | 3.388M |
| December 31, 2025 | 4.978M |
| September 30, 2025 | 6.553M |
| June 30, 2025 | 8.116M |
| March 31, 2025 | 9.612M |
| December 31, 2024 | 8.502M |
| Date | Value |
|---|---|
| September 30, 2024 | 9.94M |
| June 30, 2024 | 11.41M |
| March 31, 2024 | 12.90M |
| December 31, 2023 | 14.20M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Neumora Therapeutics, Inc. | 52.95M |
| Alumis, Inc. | 31.60M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |